The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to patients with other diseases will be lost.

A 14-year-old killed in a crash early Sunday morning was a student at South Mecklenburg High School. This legendary SNL cast member could make a robot laugh. Welcome to WatchMojo, and today we’re counting down our picks for the funniest times Bill Hader made somebody else break character on this sketch comedy show.

CMS didn't wait for President-elect Donald Trump to take office before issuing its second list of drugs to be negotiated under the Inflation Reduction Act, even though the agency had until Feb. 1 to release it.

Evercore ISI raised the firm’s price target on CMS Energy (CMS) to $73 from $64 and keeps an In Line rating on the shares. The firm maintains a

CMS has released its official 2025 mission and priorities document outlining its roadmap for state survey agencies Monday.

Teva Pharmaceuticals is suing the Centers for Medicare & Medicaid Services (CMS) for its implementation of the drug price negotiation program under the Inflation Reduction Act (IRA). | A new lawsuit from a drug manufacturer,

Alignment Healthcare is the latest Medicare Advantage (MA) insurer to accuse the Centers for Medicare & Medicaid Services (CMS) of wrongly calculating the company’s star rating scores. | Insurers, perhaps smelling blood in the water,

The work of the Innovation Center has benefited from continuity across administrations; the path to further expanding value-based care and building a health system that works for people and providers requires extending this legacy of continuity into the next administration.

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. The CMS listed Ozempic, Rybelsus and Wegovy — all forms of

CMS discusses minimum wage increase to pay its staff to be more competitive with other school districts. Carrie Underwood Speaks Out About Performing At Trump's Inauguration | Billboard News

The Centers for Medicare & Medicaid Services Jan. 13 released its standards for the health insurance marketplaces for 2026, including the issuers and brokers who assist marketplace enrollees. The final rule enhances CMS' authority to address and curtail misconduct by agents and brokers,

The Biden administration’s last MA rule is a boon for insurers, though it remains to be seen how the incoming Trump administration might put its stamp on the regulation before it’s finalized this spring.